TPB vs CIRX vs VPRB Stock Comparison

Turning Point Brands, Cirtran and VPR Brands Prices as of Oct 26, 2026 Peers: Industry group
CIRX Cirtran Corp
$0.02 -50.0% 1M +100.0% 1Y
Market cap
$98.91K
P/E
0.0x
Revenue (TTM)
$4.83M
Div. yield
–
Tobacco Consumer Staples
3 wins
VPRB VPR Brands, LP.
$0.09 +12.5% 1M +350.0% 1Y
Market cap
$8.26M
P/E
8.2x
Revenue (TTM)
$2.94M
Div. yield
–
Tobacco Consumer Staples
3 wins

Head to Head

9 decided of 12

Turning Point Brands leads on 3 of the 12 questions below (Turning Point Brands 3, Cirtran 3, VPR Brands 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionTPBCIRXVPRBLeader
Larger companyMarket capitalisation $1.34B $98.91K $8.26M TPB
Cheaper on earningsLower P/E, profitable companies only 30.1x 0.0x 8.2x CIRX
Cheaper on forward earningsLower price / next fiscal year consensus EPS 55.8x — — –
Faster revenue growthRevenue growth, trailing twelve months +24.5% +336.7% -32.5% CIRX
More profitableNet margin, trailing twelve months 8.8% 44.1% 34.1% CIRX
Better return on capitalReturn on invested capital 9.1% — -50.3% TPB
Less leveragedLower net debt / EBITDA — 5.6x — –
Higher dividend yieldTrailing dividend yield 0.00% — — –
Better 1-year returnPrice return, last 12 months -28.4% +100.0% +350.0% VPRB
Better 5-year returnAnnualised price return, 5 years +11.6%/yr -22.2%/yr +17.6%/yr VPRB
Less volatileAnnualised volatility, 1 year 56.5% 294.9% 284.6% TPB
Higher overall scoreMean of the five percentile scores vs peers 53/100 51/100 57/100 VPRB

Percentile Scorecard

TPBCIRXVPRB

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisTPBCIRXVPRB
Valuation 32 #26 of 38 43 #22 of 38 60 #16 of 38
Growth 50 #18 of 35 94 #3 of 35 32 #24 of 35
Profitability 89 #5 of 36 60 #15 of 36 80 #8 of 36
Financial Health 79 #9 of 39 5 #37 of 39 58 #17 of 39
Shareholder Returns 17 #11 of 13 – –
Overall 53 51 57
  • TPB ranked among 40 companies in Tobacco and Cannabis
  • CIRX ranked among 40 companies in Tobacco and Cannabis
  • VPRB ranked among 40 companies in Tobacco and Cannabis

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodTPBCIRXVPRBSPY
1 month +5.3%-50.0%+12.5% -0.8%
3 months -17.0%-33.3%-25.0% +3.5%
6 months -18.2%-33.3%+350.0% +7.0%
Year to date -39.8%-50.0%+200.0% +12.2%
1 year -28.4%+100.0%+350.0% +13.0%
3 years +229.2%0.0%-43.8% +86.3%
3 years, per year +48.8%0.0%-17.5% +23.1%
5 years +72.8%-71.4%+125.0% +68.6%
5 years, per year +11.6%-22.2%+17.6% +11.0%
10 years +423.7%-90.0%-83.6% +258.0%
10 years, per year +18.0%-20.6%-16.6% +13.6%

Risk

MeasureTPBCIRXVPRBSPY
Volatility, 1Y 56.5%294.9%284.6% 12.7%
Downside volatility, 1Y 66.2%647.0%457.5% 12.7%
Beta vs S&P 500, 1Y 0.611.15-3.04 1.00
Return / volatility, 1Y -0.500.341.23 1.02
Max drawdown, 5Y -61.4%-87.5%-90.9% -25.4%
From 52-week high -54.3%-66.7%-30.8% -1.8%
52-week high $142.98$0.06$0.13 $779.14
52-week low $55.23$0.01$0.02 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleTPBCIRXVPRB
P/E now vs peer median 29.2xmedian 16.5x 0.0xmedian 16.5x 8.2xmedian 16.5x
P/S now vs peer median 2.6xmedian 0.9x 0.0xmedian 0.9x 2.8xmedian 0.9x
EV/EBITDA now vs peer median —median 12.3x 5.9xmedian 12.3x —median 12.3x
P/FCF now vs peer median 66.7xmedian 23.1x -0.2xmedian 23.1x 5.5xmedian 23.1x
P/B now vs peer median 2.9xmedian 1.0x 0.0xmedian 1.0x 7.4xmedian 1.0x
PEG now vs peer median 0.56median 0.56 0.00median 0.56 1.00median 0.56

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsTPBCIRXVPRB
Revenue $507.23M $4.83M $2.94M
Gross profit $300.08M $2.27M $737.52K
Operating income $75.01M $303.56K -$1.71M
Net income $59.64M $2.13M $1.00M
Free cash flow $19.63M -$586.50K $1.51M
EPS (diluted) $2.21 $0.43 $0.01
Cash & equivalents $270.20M $158.14K $2.14M
Total debt $1.18B $9.67M $2.40M
Shares (diluted) 20.16M 4.95M 91.75M
Enterprise value $449.49M -$99.43K $2.77M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricTPBCIRXVPRB
P/E 29.2x 0.0x 8.2x
P/FCF 66.7x -0.2x 5.5x
P/Operating cash flow 40.6x -0.2x 5.5x
P/S 2.6x 0.0x 2.8x
P/B 2.9x 0.0x 7.4x
P/Tangible book 3.4x 0.0x 7.8x
EV/EBITDA – 5.9x –
EV/EBIT 17.8x 8.0x -4.0x
EV/Revenue 2.6x 0.5x 2.3x
EV/FCF 67.9x -4.1x 4.5x
EV/Operating cash flow 41.4x -4.1x 4.5x
PEG (3Y EPS CAGR) 0.56 0.00 1.00

Growth

14 metrics
MetricTPBCIRXVPRB
Revenue growth (1Y) 24.5% 336.7% -32.5%
Revenue CAGR (3Y) 11.1% 60.3% -28.2%
Gross profit growth (1Y) 31.0% 223.8% -38.8%
Gross profit CAGR (3Y) 16.3% 62.2% -33.1%
Operating income growth (1Y) -15.0% 147.0% -12.3%
Operating income CAGR (3Y) 0.3% 35.6% -62.2%
Net income growth (1Y) 23.8% 187.6% 188.4%
Net income CAGR (3Y) 69.6% 49.2% 6.8%
EPS growth (1Y) -7.6% 187.6% 188.4%
EPS CAGR (3Y) 52.4% 49.2% 8.2%
Operating cash flow growth (1Y) -46.5% 14.4% 767.4%
Operating cash flow CAGR (3Y) -14.0% -162.3% 6.5%
Free cash flow growth (1Y) -62.4% 14.4% 767.4%
Free cash flow CAGR (3Y) -24.4% -162.3% 6.5%

Profitability

14 metrics
MetricTPBCIRXVPRB
Gross margin 59.2% 46.9% 25.1%
EBITDA margin – 8.6% –
Operating margin 14.8% 6.3% -58.1%
Pretax margin 13.6% 44.1% 39.2%
Net margin 8.8% 44.1% 34.1%
FCF margin 3.9% -12.1% 51.4%
Operating cash flow margin 6.4% -12.1% 51.4%
Return on equity 14.2% – 46.4%
Return on assets 7.3% -95.4% 16.1%
Return on invested capital 9.1% – -50.3%
Return on capital employed 10.3% – -105.1%
Asset turnover 0.6x 1.9x 0.8x
Cash conversion (OCF / net income) 0.5x -0.3x 1.5x
Stock comp / revenue 1.8% – –

Financial Health

11 metrics
MetricTPBCIRXVPRB
Debt / assets 34.4% 95.6% 21.0%
Debt / equity 0.6x -0.1x 0.6x
Net debt / EBITDA – 5.6x –
Debt / FCF 15.0x -4.2x 0.5x
Liabilities / assets 46.9% 983.2% 66.7%
Equity / assets 53.1% -883.2% 33.3%
Interest coverage 2.7x 0.4x -10.1x
Current ratio 5.7x 0.1x 1.6x
Quick ratio 3.5x 0.0x 1.3x
Cash ratio 3.1x 0.0x 1.0x
Altman Z-score 3.77 -39.49 -1.19

Shareholder Returns

7 metrics
MetricTPBCIRXVPRB
Dividend yield 0.5% – –
Net buyback yield -12.2% – –
Shareholder yield -11.7% – –
Payout ratio (earnings) 10.2% – –
Payout ratio (FCF) 30.9% – –
Dividend growth (1Y) 15.9% – –
Dividend CAGR (3Y) 11.9% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusTPBCIRXVPRB
Forward P/E 55.8xFY2026 – –
EPS, next fiscal year $1.17FY2026 – –
EPS growth, next FY -62.4%FY2026 – –
EPS growth, the year after +59.0% – –
Revenue, next fiscal year $597.82MFY2026 – –
Revenue growth, next FY +29.1%FY2026 – –
Revenue growth, the year after +4.7% – –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersTPBCIRXVPRB
Held by institutions 99.9% – –
Institutions holding 231 – –
Change in shares held, QoQ +8.1% – –
Institutions buying 138 – –
Institutions selling 66 – –
Buyers to sellers 2.09 – –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

TPBCIRXVPRB
TPB 1.00 0.06 -0.04
CIRX 0.06 1.00 -0.01
VPRB -0.04 -0.01 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, TPB, CIRX and VPRB?

Turning Point Brands (TPB) is the largest by market capitalisation: Turning Point Brands (TPB) $1.34B, Cirtran (CIRX) $98.91K, VPR Brands (VPRB) $8.26M.

Which stock is cheaper, TPB, CIRX and VPRB?

Cirtran (CIRX) trades on the lowest price-to-earnings ratio (Turning Point Brands (TPB) 30.1x, Cirtran (CIRX) 0.0x, VPR Brands (VPRB) 8.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Cirtran (CIRX) grew revenue fastest over the trailing twelve months: Turning Point Brands (TPB) +24.5%, Cirtran (CIRX) +336.7%, VPR Brands (VPRB) -32.5%.

Which company is more profitable?

Cirtran (CIRX) has the highest net margin (Turning Point Brands (TPB) 8.8%, Cirtran (CIRX) 44.1%, VPR Brands (VPRB) 34.1%). On return on invested capital, Turning Point Brands (TPB) leads (Turning Point Brands (TPB) 9.1%, VPR Brands (VPRB) -50.3%).

Which stock has performed better?

Over the past year VPR Brands (VPRB) returned the most: Turning Point Brands (TPB) -28.4%, Cirtran (CIRX) +100.0%, VPR Brands (VPRB) +350.0%. Over five years, VPR Brands (VPRB) compounded fastest (Turning Point Brands (TPB) +11.6%/yr, Cirtran (CIRX) -22.2%/yr, VPR Brands (VPRB) +17.6%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Turning Point Brands (TPB) 0.00%. Cirtran (CIRX) and VPR Brands (VPRB) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Turning Point Brands (TPB) has been the steadiest (Turning Point Brands (TPB) 56.5%, Cirtran (CIRX) 294.9%, VPR Brands (VPRB) 284.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, TPB, CIRX and VPRB?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Turning Point Brands (TPB) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.